Nexvet Biopharma Announces Closing of Initial Public Offering
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/28/2026
- Stocks fall as higher oil prices, Treasury yields weigh
- S&P 500 breadth hits lowest level since dot-com bubble, Goldman says
- Nvidia’s AI dominance funds historic $150 billion buyback
- MongoDB stock drops 15% as CEO Desai resigns for Meta
- Jefferies cuts Roblox to Underperform, says rally is too optimistic
- Bloom Energy shares fall on Oracle project halt
- Exclusive-Activist Jana pushes Fiserv to accelerate cost cuts and tap Palantir
- Oppenheimer sees AI software winners as focus shifts to ROI
- Arm Holdings falls as CFO stock sale weighs on sentiment
- Cantor Fitzgerald Starts Lexicon Pharmaceuticals (LXRX) at Overweight
Nexvet Biopharma (NVET) Closes 4M Common IPO at $4/Share
February 11, 2015 6:43 AM ESTNexvet Biopharma (NASDAQ: NVET) announced the closing of its initial public offering of 4,000,000 shares of its common stock at a price to the public of $10.00 per share, resulting in aggregate gross proceeds of $40 million, before underwriting discounts, commissions and estimated offering expenses.... More
